Immunoassay Market worth $39.0 billion by 2026 - Exclusive Report by MarketsandMarkets Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, IFA, Rapid Tests, Radio Immunoassay), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Oncology), End User (Hospitals & Clinics) - Global Forecast to 2026 , published by MarketsandMarkets, the global Immunoassay Market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period.
Browse in-depth TOC on
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436
The surging incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions are the major factors driving the growth of the market.
Wound Care Market worth $27.8 billion by 2026 - Exclusive Report by MarketsandMarkets Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen, Alginate), Devices (NPWT, Debridement), Grafts, Matrices, Topical Agents, Sutures, Stapler), Wound (Traumatic, Diabetic Ulcers, Surgical, Burn), End User - Global Forecast to 2026 , published by MarketsandMarkets, the global market is projected to reach USD 27.8 billion by 2026 from USD 19.3 billion in 2021, at a CAGR of 7.6% during the forecast period.
Browse in-depth TOC on
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=371
The market growth is largely driven by factors such as the growing prevalence of chronic conditions resulting in chronic, surgical, acute, and traumatic wounds; increasing spending on chronic wounds; rising use of regenerative medicine in wound management; and technological advancements. The high growth potential of emerging economies and the growing number of ac
The market growth is largely driven by factors such as the growing prevalence of chronic conditions resulting in chronic, surgical, acute, and traumatic wounds; increasing spending on chronic wounds; rising use of regenerative medicine in wound management; and technological advancements. The high growth potential of emerging economies and the growing number of acquisitions by key players have also opened an array of opportunities for the growth of the wound care market.
The Surgical & traumatic wounds segment accounted for the largest share of the market, by wound type segment, in 2020
The wound care market, by wound type, is segmented into surgical & traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns & other wounds. In 2020, the surgical & traumatic wounds segment accounted for the largest share in the market. The increasing number of traumatic & surgical wounds is expected to drive the demand for wound care products. The market growth is also la
CHICAGO, April 22, 2021 /PRNewswire/ According to the new market research report "Immuno Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR
The rising incidence of cancer and the growing adoption of targeted therapy drives growth in the immuno-oncology assays market, increased demand for personalized medicine, and the growing significance of companion diagnostics in drug development are among the other factors. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the market.
The consumables segment accounted for the largest share of the immuno-oncology assays market, by product & service segment, in 2020
Based on product & service, the market is segmented into consumables, instruments, and software & services. The consumables segment accounted for the largest share of the market in 2020. Unlike instruments, consumables require repeat purchase, which results in their stable demand among end users.